These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16369543)

  • 21. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15.
    Bartholomeusz C; Itamochi H; Nitta M; Saya H; Ginsberg MH; Ueno NT
    Oncogene; 2006 Jan; 25(1):79-90. PubMed ID: 16170361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
    Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
    Spangenberg C; Lausch EU; Trost TM; Prawitt D; May A; Keppler R; Fees SA; Reutzel D; Bell C; Schmitt S; Schiffer IB; Weber A; Brenner W; Hermes M; Sahin U; Türeci O; Koelbl H; Hengstler JG; Zabel BU
    Cancer Res; 2006 Apr; 66(7):3715-25. PubMed ID: 16585198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation.
    Oh KB; Stanton MJ; West WW; Todd GL; Wagner KU
    Oncogene; 2007 Aug; 26(40):5950-9. PubMed ID: 17369844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells.
    Zhang P; Chen Y; Gong M; Zhuang Z; Wang Y; Mu L; Wang T; Pan J; Liu Y; Xu J; Liang R; Yuan Y
    Cell Physiol Biochem; 2018; 50(1):52-65. PubMed ID: 30326469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
    Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
    Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the Gab2 scaffolding adapter in type I interferon signalling.
    Baychelier F; Nardeux PC; Cajean-Feroldi C; Ermonval M; Guymarho J; Tovey MG; Eid P
    Cell Signal; 2007 Oct; 19(10):2080-7. PubMed ID: 17604604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy.
    Chuang TC; Liu JY; Lin CT; Tang YT; Yeh MH; Chang SC; Li JW; Kao MC
    FEBS Lett; 2007 Sep; 581(23):4443-9. PubMed ID: 17719580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinase.
    Ischenko I; Petrenko O; Gu H; Hayman MJ
    Oncogene; 2003 Sep; 22(41):6311-8. PubMed ID: 14508511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grb2 associated binder 2 couples B-cell receptor to cell survival.
    Maus M; Medgyesi D; Kövesdi D; Csuka D; Koncz G; Sármay G
    Cell Signal; 2009 Feb; 21(2):220-7. PubMed ID: 18950707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
    Masuelli L; Focaccetti C; Cereda V; Lista F; Vitolo D; Trono P; Gallo P; Amici A; Monaci P; Mattei M; Modesti M; Forni G; Kraus MH; Muraro R; Modesti A; Bei R
    Int J Oncol; 2007 Feb; 30(2):381-92. PubMed ID: 17203220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TrkA overexpression enhances growth and metastasis of breast cancer cells.
    Lagadec C; Meignan S; Adriaenssens E; Foveau B; Vanhecke E; Romon R; Toillon RA; Oxombre B; Hondermarck H; Le Bourhis X
    Oncogene; 2009 May; 28(18):1960-70. PubMed ID: 19330021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER-2/neu raises SHP-2, stops IFN-gamma anti-proliferation in bladder cancer.
    Su WP; Tu IH; Hu SW; Yeh HH; Shieh DB; Chen TY; Su WC
    Biochem Biophys Res Commun; 2007 Apr; 356(1):181-6. PubMed ID: 17346677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.
    Wang K; Ma Q; Ren Y; He J; Zhang Y; Zhang Y; Chen W
    Oncol Rep; 2007 Jan; 17(1):89-96. PubMed ID: 17143483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E
    Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal amplification and oncogene dependency of GAB2 in breast cancer.
    Bocanegra M; Bergamaschi A; Kim YH; Miller MA; Rajput AB; Kao J; Langerød A; Han W; Noh DY; Jeffrey SS; Huntsman DG; Børresen-Dale AL; Pollack JR
    Oncogene; 2010 Feb; 29(5):774-9. PubMed ID: 19881546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
    Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein.
    Brummer T; Schramek D; Hayes VM; Bennett HL; Caldon CE; Musgrove EA; Daly RJ
    J Biol Chem; 2006 Jan; 281(1):626-37. PubMed ID: 16253990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.